Why the Pro Medicus (ASX:PME) share price is climbing today

The Pro Medicus Limited (ASX: PME) share price is climbing today despite the offload of shares by its co-founders. Here's the details.

| More on:
Hands grabbing for high rung on a ladder pointing to the sky

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are climbing in morning trade despite the company announcing its co-founders have offloaded a parcel of their shares. At the time of writing, the Pro Medicus share price is up 2.5% to $46.40.

Co-founders sell shares

The Pro Medicus share price is on the rise regardless of the fact the health imaging company reported its co-founders have sold off a portion of their stake in the business.

According to this morning's release, Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall have each sold 1 million shares. The sale transacted at market close yesterday (18 February) at the price of $45.97 per share.

Pro Medius noted that the offload of shares by the co-founders represents less than 4% of their entire individual holdings. Dr Sam Hupert and Mr Anthony Hall now have 27,137,660 and 27,109,000 ordinary shares respectively after the change.

The company stated that both co-founders do not intend to sell further shares in the foreseeable future.

Words from the chair

Pro Medicus chair Peter Kempen commented on the sale of the shares:

We announced in February 2018 that the Board had encouraged the founders to consider selling up to 3 million shares each, in order to improve the liquidity in the company's shares. This latest transaction completes that process. The sale, to a number of local institutions, was done "at market" which reflects the very strong underlying demand for the company's shares.

Mr Kempen added:

Dr Hupert and Mr Hall remain actively engaged in the company and are committed to its future. This is evidenced by the fact that they remain the two key stake holders, with their combined holding post this recent sale being in excess of 52% of the shares on issue.

Pro Medicus share price snapshot

The Pro Medicus share price has been a stellar performer over the past 12 months, jumping by more than 100%. Pro Medicus shares hit a 52-week low of $14.50 in March before accelerating to an all-time high of $47.62 this week.

At the current share price of $46.60, Pro Medicus is a whisker away from breaking that feat again.

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Time to sell ASX 200 shares written on a clock.
Share Market News

Sell alert! Why analysts are calling time on these 2 ASX 300 stocks

Two leading investment experts recommend selling these ASX 300 shares today. But why?

Read more »